Helen Keller International
Helen Keller International
Ouagadougou, Burkina Faso1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Infant Mortality Reduction by the Mass Administration of Azithromycin | Child Mortality | Active, not recruiting | Phase 4 | 2025-03-13 | NCT04716712 |